ISSN: 2167-7700
Ismail Essadi, Khalid Sair, Issam Lalya, Elomrani Abderrahim, Mouna Khouchani and Rhizlane Belbaraka
Gastric cancer is one of the most commonly diagnosed cancers worldwide. Metastatic gastric cancer is correlated with a poor prognosis. Despite the large progress in cancer's treatment strategies, metastatic gastric cancer still a provider of bad outcomes. The importance of targeted therapy became clear over the last few years. This paper summarized comprehensive and current overview of the latest translational and clinical research articles and congress presentations, for a pragmatic use of targeted therapies in advanced gastric cancer.